Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Free Cash Flow (2017 - 2026)

enVVeno Medical has reported Free Cash Flow over the past 4 years, most recently at -$2.6 million for Q4 2020.

  • For Q4 2020, Free Cash Flow fell 61.43% year-over-year to -$2.6 million; the TTM value through Dec 2020 reached -$7.9 million, down 25.51%, while the annual FY2025 figure was -$15.6 million, 7.72% up from the prior year.
  • Free Cash Flow for Q4 2020 was -$2.6 million at enVVeno Medical, down from -$2.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$1.2 million in Q1 2020 and troughed at -$2.6 million in Q4 2020.
  • A 4-year average of -$1.6 million and a median of -$1.5 million in 2018 define the central range for Free Cash Flow.
  • On a YoY basis, Free Cash Flow climbed as much as 22.6% in 2020 and fell as far as 71.93% in 2020.
  • Year by year, Free Cash Flow stood at -$1.3 million in 2017, then dropped by 13.2% to -$1.4 million in 2018, then dropped by 12.93% to -$1.6 million in 2019, then crashed by 61.43% to -$2.6 million in 2020.
  • Business Quant data shows Free Cash Flow for NVNO at -$2.6 million in Q4 2020, -$2.6 million in Q3 2020, and -$1.4 million in Q2 2020.